These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8291503)

  • 1. Characterization of a low molecular weight Na-K-ATPase inhibitor of urinary origin.
    Weiler EW; Gonick HC; Prins BA; Purdy RE; Weber MA
    Am J Med Sci; 1994 Jan; 307(1):27-35. PubMed ID: 8291503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na-K-ATPase inhibitor dissociated from hypertension-associated plasma protein.
    Weiler EW; Khalil-Manesh F; Gonick HC; Prins BA; Purdy RE; Sensharma DK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):364-73. PubMed ID: 10232496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lead and a low-molecular-weight endogenous plasma inhibitor on the kinetics of sodium-potassium-activated adenosine triphosphatase and potassium-activated p-nitrophenylphosphatase.
    Weiler E; Khalil-Manesh F; Gonick HC
    Clin Sci (Lond); 1990 Aug; 79(2):185-92. PubMed ID: 2167808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lead and natriuretic hormone on kinetics of sodium-potassium-activated adenosine triphosphatase: possible relevance to hypertension.
    Weiler E; Khalil-Manesh F; Gonick H
    Environ Health Perspect; 1988 Jun; 78():113-7. PubMed ID: 2849538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ; Baecker A; Weiler E; Liddiard C
    Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC; Weiler EW; Prins BA; Purdy RE
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous natriuretic factors. 2: Characterization of natriuretic and vasopressive substances from human uremic urine.
    Levine BH; Murray ED; Bigornia AE; DeWind SA; Wechter WJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S63-8. PubMed ID: 7508032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible inhibition of sodium and potassium-dependent adenosine triphosphatase by the pyridine derivative, AU-1421 during turnover cycle.
    Takada J
    Biochem Pharmacol; 1990 Oct; 40(7):1527-31. PubMed ID: 2171532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase.
    Finotti P; Palatini P
    J Pharmacol Exp Ther; 1981 Jun; 217(3):784-90. PubMed ID: 6262496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
    Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
    Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
    Gentile DA; Skoner DP
    Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
    De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
    Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of digitalislike factors from human plasma.
    Hamlyn JM; Schenden JA; Zyren J; Baczynskyj L
    Hypertension; 1987 Nov; 10(5 Pt 2):I71-7. PubMed ID: 2824370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat brain (Na+-K+)ATPase: modulation of its ouabain-sensitive K+-PNPPase activity by thimerosal.
    Lewis RN; Bowler K
    Int J Biochem; 1983; 15(1):5-7. PubMed ID: 6298022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 5-hydroxytryptamine on sodium- and potassium-dependent adenosine triphosphatase and its reactivity toward ouabain.
    Stepp LR; Novakoski MA
    Arch Biochem Biophys; 1997 Jan; 337(1):43-53. PubMed ID: 8990266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.